Neuroprotective cannabinoid method patent claims novel compound combination #8
A filing describes neuroprotective combinations and therapeutic method claims involving cannabinoids.
AEF0117 THC Interaction Trial Withdrawn: Implications for Selective CB1 Modulation
The withdrawal of the AEF0117 trial delays progress in selective CB1 receptor modulation for managing THC-related effects. This setback impacts potential pharmacological treatments for cannabis use disorder. Clinicians and patients face longer timelines…
Study Finds Veterans With SUD Use Cannabis to Alleviate Pain and Anxiety
New research highlights cannabis veterans substance use disorder as a tool to manage pain, anxiety, and sleep issues. Veterans with SUD often turn to cannabis during treatment for safer symptom relief. This study supports integrating cannabis…
How Cannabinoids May Increase Neuromuscular Communication
Cannabinoids neuromuscular communication plays a key role in enhancing muscle function. Studies show peripheral nervous system cannabinoids may increase communication between nerves and muscles. This effect suggests potential therapies for autoimmune…
The Non-Psychoactive Cannabis Constituent Cannabidiol as an Oral Anti-Arthritic Therapeutic in Murine Arthritis
Cannabidiol oral anti-arthritic therapeutic effects have been studied in murine models of arthritis. This cannabinoid modulates immune responses and reduces inflammation. Its oral administration shows promise for arthritis symptom relief.
Benefits of Cannabidiol on Skin Cells in Psoriasis Patients Undergoing UV Therapy
Cannabidiol effects on psoriasis skin cells reveal its role in reducing oxidative stress and inflammation. However, UV irradiation treatment can compromise these benefits. Understanding this interaction is crucial for effective psoriasis management.